Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Mahner

Showing results (191-200 of 455) with videos related to

Pageof 46
Sort By:
Geburtshilfe Und Frauenheilkunde|June 25, 2026
RSV Prophylaxis in Neonates: Implementation and Parental Acceptance during the First RSV Season in GermanyEsther S Schouten, Annika S Kraft, Maria V Delius, et al.
British Journal of Cancer|January 13, 2016
E-Cadherin fragments as potential mediators for peritoneal metastasis in advanced epithelial ovarian cancerFabian Trillsch, Sascha Kuerti, Christine Eulenburg, et al.
Cancers|January 25, 2025
Necroptosis-Related Gene Signature Predicts Prognosis in Patients with Advanced Ovarian CancerMingjun Zheng, Mirjana Kessler, Udo Jeschke, et al.
JACC. Case Reports|October 10, 2025
Fetal Cardiac Magnetic Resonance Imaging in Left-Sided Diaphragmatic HerniaGloria Biechele, Nicola Fink, Julien Dinkel, et al.
Journal of Cancer Research and Clinical Oncology|September 6, 2019
EP3 receptor is a prognostic factor in TA-MUC1-negative ovarian cancerBastian Czogalla, Christina Kuhn, Sabine Heublein, et al.
Acta Obstetricia Et Gynecologica Scandinavica|November 2, 2022
Pelvic inlet area is associated with birth modeTeresa Starrach, Lisa Schmidhuber, Luisa Elger, et al.
Journal of Cancer Research and Clinical Oncology|June 4, 2021
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancerWanting Shao, Christina Kuhn, Doris Mayr, et al.
Journal of Cancer Research and Clinical Oncology|July 16, 2021
Correction to: Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancerWanting Shao, Christina Kuhn, Doris Mayr, et al.
Annals of Surgical Oncology|May 20, 2011
Prognostic value of pathological resection margin distance in squamous cell cancer of the vulvaLinn Woelber, Matthias Choschzick, Christine Eulenburg, et al.
Diagnostics (Basel, Switzerland)|April 3, 2021
Combined COX-2/PPARγ Expression as Independent Negative Prognosticator for Vulvar Cancer PatientsNadine Ansorge, Christian Dannecker, Udo Jeschke, et al.
Pageof 46

Showing results (191-200 of 455) with videos related to

Sort By:
Pageof 46
Geburtshilfe Und Frauenheilkunde|June 25, 2026
RSV Prophylaxis in Neonates: Implementation and Parental Acceptance during the First RSV Season in GermanyEsther S Schouten, Annika S Kraft, Maria V Delius, et al.
British Journal of Cancer|January 13, 2016
E-Cadherin fragments as potential mediators for peritoneal metastasis in advanced epithelial ovarian cancerFabian Trillsch, Sascha Kuerti, Christine Eulenburg, et al.
Cancers|January 25, 2025
Necroptosis-Related Gene Signature Predicts Prognosis in Patients with Advanced Ovarian CancerMingjun Zheng, Mirjana Kessler, Udo Jeschke, et al.
JACC. Case Reports|October 10, 2025
Fetal Cardiac Magnetic Resonance Imaging in Left-Sided Diaphragmatic HerniaGloria Biechele, Nicola Fink, Julien Dinkel, et al.
Journal of Cancer Research and Clinical Oncology|September 6, 2019
EP3 receptor is a prognostic factor in TA-MUC1-negative ovarian cancerBastian Czogalla, Christina Kuhn, Sabine Heublein, et al.
Acta Obstetricia Et Gynecologica Scandinavica|November 2, 2022
Pelvic inlet area is associated with birth modeTeresa Starrach, Lisa Schmidhuber, Luisa Elger, et al.
Journal of Cancer Research and Clinical Oncology|June 4, 2021
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancerWanting Shao, Christina Kuhn, Doris Mayr, et al.
Journal of Cancer Research and Clinical Oncology|July 16, 2021
Correction to: Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancerWanting Shao, Christina Kuhn, Doris Mayr, et al.
Annals of Surgical Oncology|May 20, 2011
Prognostic value of pathological resection margin distance in squamous cell cancer of the vulvaLinn Woelber, Matthias Choschzick, Christine Eulenburg, et al.
Diagnostics (Basel, Switzerland)|April 3, 2021
Combined COX-2/PPARγ Expression as Independent Negative Prognosticator for Vulvar Cancer PatientsNadine Ansorge, Christian Dannecker, Udo Jeschke, et al.
Pageof 46